A thorough examination of modern drugs that target particular receptors and metabolic pathways for glucose and fat metabolism is presented. Recent research has revealed innovative targets and ...

Today, Plantsulin blends this century-old discovery with modern scientific validation to offer a fast, convenient “whole-body reboot” for maintaining optimal glucose levels. Unlike restrictive diets ...

Glp-1 Analogues Market OverviewThe Glp analogues market size is expected to be worth USD 606.3 billion by 2034.The target market was valued at USD 45.3 billion in 2024.The market is projected to grow ...

DiabTec operates a facility equipped with 20,000-litre drug substance reactors and a separate cartridge fill-finish facility ...

Diabetes. 2014;63(5):1779-1788. On the other hand, when mice were administered with equimolar INS or ProINS as ProINS-Tf, BG levels rapidly decreased within the first 2 h and then quickly returned ...

KELIX bio, wholly owned by Mubadala Investment Company (Mubadala), said it completed the acquisition of DiabTec LLC, a subsidiary of Julphar.

This strategic investment reflects our commitment to responsible investing, addressing critical global healthcare challenges like the growing need for insulin analogues. Moreover, it strengthens ...

"This strategic investment reflects our commitment to responsible investing, addressing critical global healthcare challenges like the growing need for insulin analogues," said Bakheet Al Katheeri, ...

Many drugs, including insulin, essentially became free. But the American Rescue Plan made a major change that hit drug companies with even larger penalties for raising prices. In January 2024 ...

Key Laboratory of Colloid and Interface Chemistry, Ministry of Education, School of Chemistry and Chemical Engineering, State Key Laboratory of Crystal Material, Shandong University, Jinan 250100, ...